Laurel Wealth Advisors LLC acquired a new stake in shares of Equifax, Inc. (NYSE:EFX – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,038 shares of the credit services provider’s stock, valued at approximately $269,000.
Several other institutional investors have also recently made changes to their positions in the company. Eisler Capital Management Ltd. bought a new position in shares of Equifax during the second quarter valued at about $20,100,000. Prudential Financial Inc. grew its position in Equifax by 28.5% in the 2nd quarter. Prudential Financial Inc. now owns 84,220 shares of the credit services provider’s stock worth $21,844,000 after purchasing an additional 18,661 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Equifax by 2.6% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 854,929 shares of the credit services provider’s stock valued at $221,743,000 after buying an additional 21,684 shares during the last quarter. RBO & Co. LLC lifted its position in shares of Equifax by 0.6% during the 2nd quarter. RBO & Co. LLC now owns 69,365 shares of the credit services provider’s stock worth $17,991,000 after buying an additional 407 shares in the last quarter. Finally, Stevens Capital Management LP bought a new position in shares of Equifax during the 2nd quarter worth approximately $932,000. Institutional investors own 96.20% of the company’s stock.
Equifax Stock Down 0.6%
Equifax stock opened at $211.38 on Friday. The firm has a 50 day simple moving average of $225.08 and a 200 day simple moving average of $245.06. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.82. Equifax, Inc. has a 1-year low of $199.98 and a 1-year high of $281.07. The firm has a market capitalization of $25.87 billion, a price-to-earnings ratio of 40.11, a P/E/G ratio of 2.41 and a beta of 1.64.
Equifax Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, November 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, November 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.9%. Equifax’s dividend payout ratio is currently 37.95%.
Insider Transactions at Equifax
In related news, EVP Jamil Farshchi sold 4,925 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $238.94, for a total transaction of $1,176,779.50. Following the sale, the executive vice president owned 39,364 shares of the company’s stock, valued at approximately $9,405,634.16. This represents a 11.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Mark W. Begor sold 21,386 shares of the firm’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $231.12, for a total transaction of $4,942,732.32. Following the completion of the transaction, the chief executive officer directly owned 22,045 shares of the company’s stock, valued at approximately $5,095,040.40. The trade was a 49.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 54,270 shares of company stock worth $12,580,837. Insiders own 1.40% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently commented on EFX. Needham & Company LLC reaffirmed a “buy” rating and set a $295.00 price target on shares of Equifax in a research report on Tuesday, October 21st. UBS Group raised their target price on Equifax from $287.00 to $297.00 and gave the company a “buy” rating in a research report on Monday, September 15th. Weiss Ratings restated a “hold (c)” rating on shares of Equifax in a research report on Tuesday. Morgan Stanley reaffirmed an “overweight” rating on shares of Equifax in a research report on Friday, October 3rd. Finally, Oppenheimer initiated coverage on shares of Equifax in a research note on Monday, October 13th. They issued an “outperform” rating and a $271.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Equifax presently has an average rating of “Moderate Buy” and a consensus target price of $277.13.
Get Our Latest Stock Analysis on Equifax
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Read More
- Five stocks we like better than Equifax
- Overbought Stocks Explained: Should You Trade Them?
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Canadian Penny Stocks: Can They Make You Rich?
- SoFi Technologies: From Fintech Speculation to Profit Engine
- What is the Shanghai Stock Exchange Composite Index?
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX – Free Report).
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.
